Skip to content. | Skip to navigation

Personal tools
Log in


You are here: Home / About / Autophagy 2012

Autophagy: an Emerging Therapeutic Target in Human Disease Workshop and Symposium

Two events on Autophagy and cancer hosted by the CIHR Team in Investigating Autophagy Proteins as Molecular Targets for Cancer Treatment, led by Dr. Sharon Gorski, on February 17th and 18th, 2012. More information and how to Register below:

posterFriday, February 17, 2012    8:30AM -  4:30PM

Autophagy: an Emerging Therapeutic Target in Human Disease Workshop

Simon Fraser Harbour Centre (downtown campus)

Register securely on-line using Eventbrite.

This day long workshop will  feature presentations by research groups carrying out work related to autophagy and cancer. Workshop Agenda now available to view.

Two Keynote addresses will be given :

9:30 - 10:30 Dr. Natalie D'Amore, Associate Director of Molecular and Cellular Oncology for Millennium: The Takeda Oncology Company

3:30 - 4:30 Dr. Ravi Amaravadi, Assistant Professor of Medicine at the University of Pennsylvania

A scientific poster session will be held during the day, and a cash award for the best student poster will be presented.

Discussions will be moderated by:  Dr. Sharon Gorski (Simon Fraser University, BC Cancer Agency), Prof. Robert Young (Merck Frosst - B.C. Discovery Chair in Pharmareutical Genomics, Bioinformatics and Drug Discovery, Simon Fraser University), Dr. Julian Lum (BC Cancer Agency - Deeley Research Centre). Prof. Tessa Holyoake, University of Glasgow will be participating.


Saturday, February 18, 2012    1:30PM -  4:30PM

AAAS 2012 Annual Meeting Symposium Track: Discovery

Autophagy: an Emerging Therapeutic Target in Human Disease

Vancouver Convention Center

Register at

Moderator: Sharon M. Gorski, BC Cancer Agency and Simon Fraser University


Natalie D'Amore, Millennium: The Takeda Oncology Company Autophagy Research: An Industrial Perspective

Tessa Holyoake, University of Glasgow Targeting the Autophagy Pathways in Chronic Myeloid Leukemia Stem Cells

Robert N. Young, Simon Fraser University Novel Assays and Inhibitors of the Key Autophagy Protease

Ravi Amaravadi, University of Pennsylvania Autophagy Inhibition in Cancer Therapy: Progress and Unanswered Questions

For further information contact:


Stephanie McInnis, Project Manager
Genome Sciences Centre, BC Cancer Agency
Phone: 604-675-8000 x 7965
Page last modified Feb 06, 2012